Fundraising FoxSono Motion
San Mateo, US · Washington corporation · 1 known investors
Find your way into Sono Motion
Sign up to see every warm intro you have to Sono Motion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sono Motion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners. The company focuses on less invasive stone management technologies and has advanced these through clinical trials and regulatory efforts.
Founders & leadership
OL
Oren LevyChief Executive Officer, Co-FounderOren Levy is co-founder and CEO of SonoMotion, an ultrasound-based medical device company developing treatments for kidney stones. He has held leadership roles in medical device development across cardiovascular and ultrasound imaging technologies, including prior involvement with Fluid Medical, and has managed cross-functional R&D teams in both large corporations and early-stage ventures.
PD
Paul Douglas CorlExecutive
DC
Doug CorlChief Technology Officer
MB
Michael BaileyNamed on SEC filing
BD
Barbrina DunmireNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.4M disclosed across 4 rounds · 2016–2022
▶$11.5MraisedApr 2022 · 4 investors · BiotechnologyRule 506(b)
▶$11.5MraisedApr 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Takashi FukuyamaDirector
- Abel AngDirector
- Michael BaileyDirector
- Oren LevyExecutive Officer, Director, Promoter
- Jeff BarnesDirector
- Offering amount
- $14.4M
- Amount sold
- $11.5M
- First sale
- Apr 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.3MraisedApr 2019 · 3 investors · Other TechnologyRule 506(b)
▶$3.3MraisedApr 2019 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff BarnesDirector
- Oren LevyExecutive Officer, Director, Promoter
- Michael BaileyDirector
- Takashi FukuyamaDirector
- Offering amount
- $17.5M
- Amount sold
- $3.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$4.5MraisedApr 2017 · 3 investors · Other TechnologyRule 506(b)
▶$4.5MraisedApr 2017 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BaileyDirector
- Oren LevyExecutive Officer, Director, Promoter
- Takashi FukiyamaDirector
- Jeff BarnesDirector
- Offering amount
- $4.6M
- Amount sold
- $4.5M
- First sale
- Apr 2017
- Incorporated
- Corporation, Washington, 2012
- Federal exemptions
- 06b
▶$100KraisedJul 2016 · 2 investors · Other TechnologyRule 506(b)
▶$100KraisedJul 2016 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul Douglas CorlExecutive Officer
- Oren LevyExecutive Officer, Director
- Michael BaileyExecutive Officer, Director
- Barbrina DunmireDirector
- Offering amount
- $500K
- Amount sold
- $100K
- First sale
- Jul 2016
- Incorporated
- Corporation, Washington, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Sono Motion.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $400K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $999.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $207.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $961.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sono Motion do?
- SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners. The company focuses on less invasive stone management technologies and has advanced these through clinical trials and regulatory efforts.
- Who founded Sono Motion?
- Sono Motion was founded by Oren Levy.
- Who are Sono Motion's investors?
- Sono Motion's investors include Bioventures Investors.
- How much funding has Sono Motion raised?
- Sono Motion has disclosed $19.4M raised across 4 rounds.
- Where is Sono Motion headquartered?
- Sono Motion is headquartered in San Mateo, US.